Table of Contents

company-logo

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Tandem Diabetes Care Dividend Announcement

• Tandem Diabetes Care does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Tandem Diabetes Care dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Tandem Diabetes Care Dividend History

Tandem Diabetes Care Dividend Yield

Tandem Diabetes Care current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Tandem Diabetes Care stock? Use our calculator to estimate your expected dividend yield:

Tandem Diabetes Care Financial Ratios

P/E ratio-15.64
PEG ratio-2.49
P/B ratio9.13
ROE-49.43%
Payout ratio0.00%
Current ratio3.05
Quick ratio2.38
Cash Ratio0.20

Tandem Diabetes Care Dividend FAQ

Does Tandem Diabetes Care stock pay dividends?
Tandem Diabetes Care does not currently pay dividends to its shareholders.
Has Tandem Diabetes Care ever paid a dividend?
No, Tandem Diabetes Care has no a history of paying dividends to its shareholders. Tandem Diabetes Care is not known for its dividend payments.
Why doesn't Tandem Diabetes Care pay dividends?
There are several potential reasons why Tandem Diabetes Care would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Tandem Diabetes Care ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Tandem Diabetes Care has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Tandem Diabetes Care a dividend aristocrat?
Tandem Diabetes Care is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Tandem Diabetes Care a dividend king?
Tandem Diabetes Care is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Tandem Diabetes Care a dividend stock?
No, Tandem Diabetes Care is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Tandem Diabetes Care stocks?
To buy Tandem Diabetes Care you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Tandem Diabetes Care stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.